Learn More
Medchemexpress LLC Bragsin1 | 369631-68-5 | 99.91% | 273.16 | 50 MG

Supplier: Medchemexpress LLC HY111549100MG
Bragsin1 is a potent, selective, and noncompetitive inhibitor of the ArfGEF BRAG2, which inhibits Arf GTPase activation, with an IC50 of 3 μM. It binds to the PH domain of BRAG2 and acts as a noncompetitive interfacial inhibitor. Bragsin1 does not affect the Sec7 domain of human ArfGEFs and shows anti-cancer activity.
- Potent, selective, and noncompetitive inhibitor of ArfGEF BRAG2.
- Inhibits Arf GTPase activation with an IC50 of 3 μM.
- Binds to the PH domain of BRAG2.
- Acts as a noncompetitive interfacial inhibitor.
- Does not affect the Sec7 domain of human ArfGEFs.
- Shows anti-cancer activity.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.